Malaria IPTi with pyrimethamine/sulfadoxine “highly cost-effective” Clinical study 23 January 2013 Pages: 1 - 1
New marketing campaigns by large US chains such as Wal-Mart, Stop and Shop and Publix to provide free prescribed antibacterials to customers have been strongly opposed Media release 23 January 2013 Pages: 3 - 3
The Turkish Government has added Wyeth's pneumococcal 7-valent CRM197 vaccine conjugate [Prevenar] to its National Immunisation Schedule Media release 23 January 2013 Pages: 3 - 3
Access to essential medicines for kids poor in central Africa Clinical study 23 January 2013 Pages: 5 - 5
Irbesartan a worthwhile choice for hypertension in Sweden Clinical study 23 January 2013 Pages: 5 - 5
Grass pollen allergy vax tops standard care in rhinitis + asthma Clinical study 23 January 2013 Pages: 6 - 6
Typhoid vax “deserves careful consideration” in high-incidence areas Clinical study 23 January 2013 Pages: 7 - 7
The growing number of Americans suffering from multiple chronic diseases demonstrates the need for focus on primary and secondary prevention Media release 23 January 2013 Pages: 8 - 8
Measuring QOL scores is a “meaningful” way to assess the benefit of chemotherapy Clinical study 23 January 2013 Pages: 9 - 9
A biological drug that is superior to Boehringer Ingelheim/Pfizer's roflumilast [Spiriva] in reducing COPD exacerbations would earn a higher patient share in Europe Media release 23 January 2013 Pages: 10 - 10
The National Cancer Coalition (NCC) and Wyeth Pharmaceuticals have announced a pilot programme to assist cancer patients in Latin America Media release 23 January 2013 Pages: 11 - 11
Decision Resources has found that a drug for treating stage IV malignant melanoma Media release 23 January 2013 Pages: 11 - 11
GlaxoSmithKline's ofatumumab is likely to become the new gold standard treatment for relapsed/refractory chronic lymphocytic leukaemia Media release 23 January 2013 Pages: 11 - 11